期刊文献+

西红花酸对糖尿病大鼠体内晚期糖基化终产物的形成及其受体表达的影响 被引量:14

Effects of crocetin on formation of advanced glycation end products and expression of releptor for advanced glycation and prodmts protein in diabetic rats
下载PDF
导出
摘要 目的:观察西红花酸对糖尿病(diabetic melli-tus,DM)大鼠晚期糖基化终产物(AGEs)的形成和受体(RAGE)蛋白表达的影响。方法:以链脲佐菌素诱导DM大鼠模型,并将DM大鼠随机分为DM模型组和西红花酸治疗组(50 mg.kg-1.d-1),另设正常组,给药21 d后,血糖仪测定大鼠空腹血糖;试剂盒分别测定AGEs中间产物即血清果糖胺(FMN)和糖化血红蛋白(GHb)的含量;荧光分光光度法测定主动脉及肠系膜血管床AGEs的水平;病理切片观察肠系膜动脉的变化;免疫组化法检测RAGE蛋白在肠系膜动脉中的表达。结果:西红花酸治疗后,对DM大鼠血糖值无明显影响;但FMN和GHb水平与模型组比明显下降;AGEs在主动脉和肠系膜血管床中沉积减少;肠系膜动脉血管损伤减轻;RAGE蛋白表达显著下降。结论:西红花酸可抑制蛋白质非酶糖化反应,减少AGEs及其中间产物的形成,下调RAGE蛋白表达,保护DM大鼠血管。 AIM: To study the effect of crocetin on the formation of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) protein expression in diabetic rats induced by streptozotocin (STZ). METHODS: Rats were injected STZ in tail vessel with a dose of 45 mg·kg^-1. 3 d later, the rats whose blood glucose were over 11.1 mmol·L^-1 were regarded as diabetic rats, and were divided randomly into two groups: diabetic mellitus (DM) group, eroeetin (50 mg·kg^-1, po) group. At the same time, 8 normal rats were regarded as control group. After 21 d treatment, The levels of fasting blood glucose (FBG), serum fmetosamine (FMN) and glycosylated hemoglobin (GHb) were measured. The contents of AGEs in aorta and mesenterie vessel were detected by fluorospectrophotometry. HE staining for mesenterie aorta was performed, and RAGE protein expression was studies with immunohistochemical method. RESULTS: Compared with DM group, crocetin' did not decrease the level of FBG. However, it could decrease the levels of FMN and GHb in blood and AGEs in aorta and mesenteric vessel (P 〈 0.01 or 0.05). HE staining demonstrated injure of mesenteric aorta attenuated and RAGE protein expression decreased after crocetin treatment. CONCLUSION: These results suggest that crocetin not only inhibit nonenzymatic glycation reaction but also reduce RAGE protein expression in diabetic rats, which may contribute to attenuate diabetic vascular complications.
出处 《中国临床药理学与治疗学》 CAS CSCD 2006年第4期448-452,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 西红花酸 晚期糖基化终产物 晚期糖基化终产物受体 糖尿病 糖尿病血管病变 crocetin advanced glycation endoproducts receptor for advanced glycation endoproducts diabetic mellitus diabetic vascular complication
  • 相关文献

参考文献23

  • 1Zimmet P, Albeti KG, Shaw J. Global and societal implications of the diabetes epidemic[J]. Nature, 2001 ; 414:782 - 7
  • 2Rojas A, Morales MA. Advanced glycation and endothelial functions: A link towards vascular complications in diabetes[J].Life Sciences,2004; 76:715 - 30
  • 3Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications[J]. Diabetes Res Clin Pract,2005; 67:3- 21
  • 4Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: a scaffold for the macrovascular comphcations of diabetes and beyond[J]. Circ Res, 2003; 93 : 1159-69
  • 5李文娜,钱之玉.西红花酸对阿霉素所致大鼠心肌线粒体损伤的影响[J].中国临床药理学与治疗学,2005,10(7):764-767. 被引量:7
  • 6Xi L, Qian ZY, Shen XC, Wen N, Zhang YB. Crocetin prevents dexamethasone-induced insulin resistance in rats [ J ].Planta Med, 2005; 71:917-22
  • 7王雅娟,钱之玉,沈祥春.西红花酸对体外蛋白质非酶糖基化的抑制作用[J].中草药,2005,36(8):1202-1205. 被引量:11
  • 8Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S,et al. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products[J]. J Clin Invest, 1997;99:1016 - 27
  • 9Makita M, Vlassara H, Cerami A, Bucala R. Immunochemical detection of advanced glycosylation end products in vivo[J]. J Biol Chem, 1992; 257: 5133- 8
  • 10Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerrnan GA,McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders [ J]. Blood, 1998; 91 :3527 - 60

二级参考文献31

  • 1葛勇,张家庆,周云平.水飞蓟宾及槲皮素对体外白蛋白非酶糖化的抑制作用[J].第二军医大学学报,1995,16(4):333-336. 被引量:33
  • 2徐霆,江文,李生广,赵保路,忻文娟,林治焕.镁离子对阿霉素线粒体毒性的防护作用[J].生物物理学报,1995,11(4):614-618. 被引量:10
  • 3李文娜,钱之玉.西红花酸对多柔比星致大鼠心脏毒性的影响[J].中国新药杂志,2005,14(10):1165-1169. 被引量:6
  • 4Xi L, Qian Z Y, Shen X C, et al. Crocetin prevents dexam ethasone-induced insulin resistance in rats [J]. Planta Med,2005, 71: 1-6.
  • 5Neeper M, Schmidt A M, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins [J]. J Biol Chem, 1992, 267 (21):14998-15004.
  • 6MarrinG, Goh E, Neff A W. Evaluation of the developmental toxicity of crocetin on Xenopus [J]. Food Chem Toxicol,2002, 40(7): 959-964.
  • 7Abe R, ShimizuT, Sugawara H, etal. Regulation of human melanoma growth and metastasis by AGE AGE receptor interactions [J]. J Invest Dermatol, 2004, 122(2): 461-467.
  • 8Brodsky S V, Gealekman O, Chen J, et al. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen [J]. Circ Res,2004. 94(3): 377-384.
  • 9Brownlee M, Vlassara H, Kooney A, et al. Aminoguanidine prevents diabetes induced arterial wall protein cross-linking[J]. Science, 1986, 232(27): 1629-1632.
  • 10ZhuBH GuanYY.Diabetes complications and PKC [J].中国药理学通报,2000,16(1):4-6.

共引文献16

同被引文献192

引证文献14

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部